rs398123013
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_020944.3(GBA2):c.700C>T(p.Arg234*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000026 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020944.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 46Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive cerebellar ataxia with late-onset spasticityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GBA2 | ENST00000378103.7 | c.700C>T | p.Arg234* | stop_gained | Exon 4 of 17 | 1 | NM_020944.3 | ENSP00000367343.3 | ||
| GBA2 | ENST00000378094.4 | c.700C>T | p.Arg234* | stop_gained | Exon 4 of 17 | 1 | ENSP00000367334.4 | |||
| GBA2 | ENST00000467252.5 | n.272C>T | non_coding_transcript_exon_variant | Exon 1 of 13 | 1 | |||||
| GBA2 | ENST00000485259.1 | n.279C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251470 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461724Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727172 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74310 show subpopulations
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 46 Pathogenic:3
- -
This variant is interpreted as a Pathogenic for Spastic paraplegia 46, autosomal recessive. The following ACMG Tag(s) were applied: PM2 : Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PS3-Moderate : PS3 downgraded in strength to Moderate (PMID:26220345). PVS1 : Predicted nullvariant in a gene where LOF is a known mechanism of disease. PP1 : Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (PMID:23332917). -
Variant confirmed as disease-causing by referring clinical team -
Spastic paraplegia Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg234*) in the GBA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GBA2 are known to be pathogenic (PMID: 23332916, 23332917). This variant is present in population databases (rs398123013, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 23332916). ClinVar contains an entry for this variant (Variation ID: 41486). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at